论文信息 - CD16-IL15-CD33 Trispecific Killer Engager (TriKE) Overcomes Cancer-Induced Immune Suppression and Induces Natural Killer Cell-Mediated Control of MDS and AML Via Enhanced Killing Kinetics - 字舞流文

CD16-IL15-CD33 Trispecific Killer Engager (TriKE) Overcomes Cancer-Induced Immune Suppression and Induces Natural Killer Cell-Mediated Control of MDS and AML Via Enhanced Killing Kinetics

CD16-IL15-CD33 Trispecific Killer Engager (TriKE) Overcomes Cancer-Induced Immune Suppression and Induces Natural Killer Cell-Mediated Control of MDS and AML Via Enhanced Killing Kinetics

J. Tolar | Jeffrey S. Miller | S. Spellman | D. Weisdorf | B. Blazar | B. Önfelt | M. Verneris | D. Vallera | S. Cooley | R. McElmurry | E. Warlick | A. Lenvik | M. Felices | Elizabeth P Taras | D. Sarhan | L. Brandt | K. Guldevall | S. Chu